936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses
    Journal Article

    Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • The impact of Li-Fraumeni and germline retinoblastoma mutations on leiomyosarcoma initiation, outcomes, and genetic testing recommendations
    Journal Article

    Dermawan, J. K.; Abramson, D. H.; Chiang, S.; Hensley, M. L.; Tap, W. D.; Movva, S.; Maki, R. G.; Mandelker, D.; Antonescu, C. R.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Biomarker analyses investigating disease biology and associations with outcomes in the JAVELIN Merkel 200 trial of avelumab in metastatic Merkel cell carcinoma
    Journal Article

    D'Angelo, S. P.; Lebbé, C.; Nghiem, P.; Brohl, A. S.; Mrowiec, T.; Leslie, T.; Georges, S.; Güzel, G.; Shah, P.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Expect the unexpected: Fulminant myocardial cytotoxic injury from Trabectedin
    Journal Article

    Tsay, A. J.; Satish, M.; Corley, E.; Ezema, A.; DeJesus, N.; Wisely, S.; McAleer, E.; Zhang, C.; Yuan, S.; Homan, E.; more...
    Cardio-Oncology (2024)

    Fulltext@MSK | Save
  • INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT exon 11 + 17/18 mutations
    Meeting Abstract

    Zalcberg, J. R.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Cox, P.; Sherman, M. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Peak study: A phase 3, randomized, open-label multicenter clinical study of bezuclastinib (CGT9486) and sunitinib in combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Heinrich, M. C.; Somaiah, N.; Trent, J. C.; Wilky, B. A.; Burgess, M. A.; Singh, A. S.; Attia, S.; Agulnik, M.; Tap, W. D.; Bauer, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma
    Journal Article

    Bozzo, A.; Hollingsworth, A.; Chatterjee, S.; Apte, A.; Deng, J.; Sun, S.; Tap, W.; Aoude, A.; Bhatnagar, S.; Healey, J. H.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: Retrospective study from the Ultra-Rare Sarcoma Working Group
    Journal Article

    Giani, C.; Denu, R. A.; Ljevar, S.; Gronchi, A.; Napolitano, A.; Rosenbaum, E.; Salawu, A.; Bajpai, J.; Connolly, E. A.; Lee, A. T. J.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • CSF1R inhibition in patients with advanced solid tumors or tenosynovial giant cell tumor: A phase I study of vimseltinib
    Journal Article

    Gelderblom, H.; Razak, A. A.; Taylor, M. H.; Bauer, T. M.; Wilky, B.; Martin-Broto, J.; Gonzalez, A. F.; Rutkowski, P.; Szostakowski, B.; Alcindor, T.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor
    Meeting Abstract

    Dai, D.; Tecson, K.; Pan; Ye, X.; Tap, W. D.
    Value in Health (2024)

    Fulltext@MSK | Save